Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis.
Sungkanuparph
Somnuek
S
Vibhagool
Asda
A
Mootsikapun
Piroon
P
Chetchotisakd
Ploenchan
P
Tansuphaswaswadikul
Somsit
S
Bowonwatanuwong
Chureeratana
C
Chantratita
Wasun
W
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy*; D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D048588:Benzoxazines; D018791:CD4 Lymphocyte Count; D003455:Cryptococcus neoformans; D003521:Cyclopropanes; D005260:Female; D006678:HIV / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D008297:Male; D016919:Meningitis, Cryptococcal / Q000150:complications* / Q000382:microbiology; D010078:Oxazines / Q000009:adverse effects / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D013785:Thailand; D013997:Time Factors
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D012367:RNA, Viral; C098320:efavirenz